Latest News & Features
Big Pharma
Eli Lilly has lost the latest round of its patent battle with Allergan centring on the lung cancer drug Alimta. 15 February 2016
Africa
GSK has been fined more than £37 million by the UK government for “anti-competitive conduct” in relation to ‘pay for delay’ deals centring on anti-depressant drug Seroxat. 12 February 2016
Americas
The US Supreme Court should reject a petition arguing that the US Court of Appeals for the Federal Circuit’s should not handle interference proceedings, the Japanese Foundation for Cancer Research has argued. 11 February 2016
Big Pharma
Law firm Fieldfisher has expanded its life sciences patent litigation and intellectual property practice by hiring Diana Sternfeld, Nicole Jadeja, and Rebecca Baines as partners. 11 February 2016
Americas
Mylan has proposed to buy Swedish pharmaceutical company Meda in what would be a $7.2 billion deal. 11 February 2016
Americas
An advisory committee at the US Food and Drug Administration has said that pharmaceutical company Celltrion’s proposed biosimilar used to treat Crohn’s disease and rheumatoid arthritis should be approved for sale. 10 February 2016
Americas
A biotechnology company that licenses a patent related to the gene-editing technology CRISPR/Cas9 has raised more than $94 million in its initial share offering. 10 February 2016
Asia
India’s weak intellectual property enforcement regime and its vague grounds centring on compulsory licences for drugs are reasons it should remain on the “Priority Watch List” in this year’s "Special 301 Report", a pharmaceutical industry association has argued. 9 February 2016
Big Pharma
Law firm Carpmaels & Ransford has hired David Wilson and Jake Marshall as partners in the firm’s patent litigation and life sciences practices. 9 February 2016
Americas
Supernus Pharmaceuticals has defeated Actavis in a patent infringement dispute centring on epilepsy drug Oxtellar XR. 8 February 2016